A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris

• Status: Completed
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study will evaluate the effect of dapsone gel in female subjects with skin of color (Fitzpatrick Skin Types IV, V, and VI) with acne vulgaris.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Dapsone

Criteria

Inclusion Criteria:

• Diagnosis of acne vulgaris

• Medium to dark complexion (Fitzpatrick Skin Type IV, V or VI)

• Willing to avoid excessive or prolonged exposure of the face to ultraviolet light (eg, sunlight, tanning beds) throughout the study

Exclusion Criteria:

• Received treatment with botulinum toxin of any serotype in the face within 6 months